These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3375885

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Control of hyperkalemia with fludrocortisone in a patient with systemic lupus erythematosus.
    Dreyling KW, Wanner C, Schollmeyer P.
    Clin Nephrol; 1990 Apr; 33(4):179-83. PubMed ID: 2350905
    [Abstract] [Full Text] [Related]

  • 3. Hyperkalemia associated with indomethacin.
    Goldszer RC, Coodley EL, Rosner MJ, Simons WM, Schwartz AB.
    Arch Intern Med; 1981 May; 141(6):802-4. PubMed ID: 7016059
    [Abstract] [Full Text] [Related]

  • 4. Indomethacin-induced hyperkalemia in three patients with gouty arthritis.
    Findling JW, Beckstrom D, Rawsthorne L, Kozin F, Itskovitz H.
    JAMA; 1980 Sep 05; 244(10):1127-8. PubMed ID: 7411769
    [Abstract] [Full Text] [Related]

  • 5. Nephrotoxicity from nonsteroidal anti-inflammatory drugs.
    Reeves WB, Foley RJ, Weinman EJ.
    South Med J; 1985 Mar 05; 78(3):318-22. PubMed ID: 3975749
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression.
    Heering PJ, Kurschat C, Vo DT, Klein-Vehne N, Fehsel K, Ivens K.
    Clin Transplant; 2004 Apr 05; 18(2):186-92. PubMed ID: 15016134
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Indomethacin-induced hyperkalemia and renal failure in multiple myeloma.
    Paladini G, Tonazzi C.
    Acta Haematol; 1982 Apr 05; 68(3):256-60. PubMed ID: 6814155
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine.
    Kamel KS, Ethier JH, Quaggin S, Levin A, Albert S, Carlisle EJ, Halperin ML.
    J Am Soc Nephrol; 1992 Feb 05; 2(8):1279-84. PubMed ID: 1627752
    [Abstract] [Full Text] [Related]

  • 13. Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism.
    Sebastian A, Schambelan M, Lindenfeld S, Morris RC.
    N Engl J Med; 1977 Sep 15; 297(11):576-83. PubMed ID: 18672
    [Abstract] [Full Text] [Related]

  • 14. Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism.
    Tan SY, Shapiro R, Franco R, Stockard H, Mulrow PJ.
    Ann Intern Med; 1979 May 15; 90(5):783-5. PubMed ID: 434681
    [Abstract] [Full Text] [Related]

  • 15. Hyporeninemic hypoaldosteronism, sodium wasting and mineralocorticoid-resistant hyperkalemia in two patients with obstructive uropathy.
    Pelleya R, Oster JR, Perez GO.
    Am J Nephrol; 1983 May 15; 3(4):223-7. PubMed ID: 6351617
    [Abstract] [Full Text] [Related]

  • 16. [Type IV renal tubular acidosis: pathogenetic role of aldosterone deficiency and hyperkalemia].
    Schambelan M, Sebastian A.
    Nephrologie; 1985 May 15; 6(3):135-7. PubMed ID: 3908957
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cyclosporine nephrotoxicity and early posttransplant hyperkalemia in living-donor renal recipients: report of 4 cases.
    Pavleska-Kuzmanovska S, Popov Z, Ivanovski O, Ristovska V, Masin-Spasovska J, Rambabova-Busljetic I, Ivanovski N.
    Exp Clin Transplant; 2014 Oct 15; 12(5):479-83. PubMed ID: 24417207
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.